CRMD — CorMedix Inc

Stock analysis, trade plans, and proprietary indicators by Trend Edge.

About CorMedix Inc

CorMedix Inc., a biopharmaceutical company, focuses on developing and commercializing therapeutic products for life-threatening diseases and conditions in the United States. Its lead product candidate is DefenCath, an antimicrobial catheter lock solution to reduce the incidence of catheter-related bloodstream infections in adult patients with kidney failure. Read full Trend Edge analysis →

Trend Edge Proprietary Indicators

Key Metrics

Current Price$8.46
Market Cap$632M
Float66.6M
Shares Outstanding78.5M
P/E (Forward)15.80
P/E (TTM)3.71
Price/Sales (TTM)1.58
vs. Analyst Target+77.3% to analyst PT
Profit Margin45.25%
Operating Margin (TTM)49.96%
Revenue (TTM)$400M
Earnings Growth (YoY)42.80%
Dividend RateNone
Analyst Target Price$15.00 (6 analysts)

Financial History

Annual Revenue & Earnings History

YearRevenueNet IncomeGross ProfitEBITDA
2020 $239,231 -$22.0M $34,385 -$27.0M
2021 $190,936 -$28.2M $41,998 -$29.4M
2022 $65,408 -$29.7M $61,674 -$30.1M
2023 N/A -$46.3M -$205,562 -$46.2M
2024 $43.5M -$17.9M $40.3M -$19.0M
2025 $312M $163M $276M $165M

Recent Quarterly Revenue & Net Income

QuarterRevenueNet Income
Jun 2025 $39.7M $19.8M
Sep 2025 $104M $109M
Dec 2025 $129M $14.0M
Mar 2026 $127M $38.6M

Ownership & Float

Insider Ownership7.5%
Institutional Ownership55.0%
Short Float24.4%
% of All Funds Holding2.13%
Number of Funds Holding175

Current Moving Averages

Trend Edge tracks near-term, medium-term, cyclical, and secular moving averages across weekly and monthly timeframes to identify trend structure at every horizon.

TimeframeSMAValueTrend Context
Weekly10-Week SMA$7.55Near-term / short-term trend
Weekly40-Week SMA$9.27Medium-term trend
Weekly80-Week SMA$9.94Cyclical trend (business cycle)
Weekly200-Week SMA$6.76Secular trend (multi-year)
Monthly10-Month SMA$9.68Near-term monthly trend
Monthly20-Month SMA$9.84Medium-term monthly trend
Monthly40-Month SMA$7.15Secular monthly trend

Volume Shelves — Support & Resistance

Trend Edge identifies volume shelves: price zones where historically elevated trading volume creates structural support or resistance. A volume shelf forms when a disproportionate share of cumulative volume was transacted at a specific price level, making it a high-conviction anchor for future price reactions.

Price LevelTypeVolume RatioAge
$11.80 resistance 1.42x 3 months ago
$14.80 resistance 2.12x 7 months ago
$6.10 support 1.25x 12 months ago
$4.60 support 1.20x 20 months ago
$4.30 support 1.38x 24 months ago

Historical Earnings Reactions (63 events)

TimeframeAvg ReturnMedianWin RateBestWorst
Gap 0.24% 0.00% 46.03% 19.05% -12.39%
1 Day -0.02% 0.00% 46.03% 20.06% -17.70%
1 Week 1.20% 0.00% 47.62% 29.45% -34.48%
2 Weeks 5.29% 3.58% 56.45% 42.36% -22.58%
1 Month 6.29% -0.01% 50.00% 84.72% -36.28%

Next earnings: August 2, 2026 (66 days away)

Seasonality & Day-of-Week Patterns

Monthly Seasonality

MonthAvg ReturnWin RateSamples
Jan13.5%62.5%16
Feb6.6%50.0%16
Mar4.2%50.0%16
Apr-0.5%50.0%16
May-12.3%20.0%15
Jun5.3%56.3%16
Jul5.3%43.8%16
Aug2.7%56.3%16
Sep2.6%37.5%16
Oct4.4%43.8%16
Nov4.7%43.8%16
Dec5.8%43.8%16

Day-of-Week Tendencies

DayAvg ReturnWin RateSamples
Monday 0.12% 42.4% 754
Tuesday -0.29% 40.2% 830
Wednesday 0.38% 44.6% 826
Thursday 0.22% 42.0% 811
Friday 0.51% 46.1% 811

Top Institutional Holders

Institutional holder breakdown coming soon.

Total institutional ownership: 55.0%

Insider Transactions — Smart Summary

Total insider ownership: 7.5%

12-Month Insider Activity Summary

Total Filings13
Net Value-$2.1M
Net Shares Change-76,225
% of Float-0.1%
C-Suite Filings4
Clusters Detected1

Key Insiders

NameTitleNet ValueFilingsActivity
Todisco Joseph Chief Executive Officer -$723,983.5 1 1 sell
Hurlburt Elizabeth Chief Operating Officer -$633,519.803 1 1 sell
Dillione Janet -$577,039.515 3 2 sell
Zelnick Kaufman Beth Chief Legal Officer -$505,265 1 1 sell
Lefkowitz Steven W -$475,200 1 1 sell
Kaplan Myron +$275,500 1 1 buy
DUNTON ALAN W -$275,200 2 1 sell

Transaction Clusters

PeriodFilingsInsidersNet ValueSeniority
2025-09-11 – 2025-09-16 4 4 -$2.0M 3 C-suite

Significant Filings

DateInsiderTitleNet ValuePrice After
2025-10-27 Kaplan Myron +$275,500 Transaction at $11.02, now -23.2%
2025-12-10 Lefkowitz Steven W -$475,200 Transaction at $11.88, now -28.8%
2025-09-12 Todisco Joseph Chief Executive Officer -$723,983.5 Transaction at $9.38, now -9.8%
2025-11-18 Dillione Janet -$342,600 Transaction at $11.42, now -25.9%
2025-09-11 Zelnick Kaufman Beth Chief Legal Officer -$505,265 Transaction at $8.35, now +1.3%
2025-09-11 Hurlburt Elizabeth Chief Operating Officer -$633,519.803 Transaction at $7.32, now +15.6%

View full insider transaction history on Trend Edge →

AI Consult Analysis

Trend Edge's AI Consult feature delivers a comprehensive, multi-layer trade plan for CorMedix Inc (CRMD) powered by Claude Opus — Anthropic's most capable AI model. The analysis covers five layers: technical analysis (near-term, medium-term, cyclical, and secular trend, momentum, volume shelf support and resistance, breakout and breakdown signals), qualitative analysis (business model, competitive moat, sector dynamics), insider sentiment (buy and sell signals from executive and director transactions), share stats analysis (institutional accumulation, fund positioning, short float squeeze potential), and fundamental analysis (valuation, revenue growth, profit margin, earnings quality).

AI Consult synthesizes all five layers into a single bullish or bearish thesis with explicit entry, exit, stop loss, and take profit levels — giving you a complete, AI-powered trade plan with defined risk/reward. Whether you are building a long position, initiating a short, or looking for a reversal setup, AI Consult identifies the highest-probability signal from the current trend.

Get the full AI Consult analysis for CRMD on Trend Edge →